These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10636754)

  • 1. Increased mortality associated with growth hormone treatment in critically ill adults.
    Osterziel KJ; Dietz R; Ranke MB
    N Engl J Med; 2000 Jan; 342(2):134-5; author reply 135-6. PubMed ID: 10636754
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased mortality associated with growth hormone treatment in critically ill adults.
    Van den Berghe G
    N Engl J Med; 2000 Jan; 342(2):135; author reply 135-6. PubMed ID: 10636755
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased mortality associated with growth hormone treatment in critically ill adults.
    Takala J; Ruokonen E; Webster NR; Nielsen MS; Zandstra DF; Vundelinckx G; Hinds CJ
    N Engl J Med; 1999 Sep; 341(11):785-92. PubMed ID: 10477776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone therapy in critically ill patients.
    Demling R
    N Engl J Med; 1999 Sep; 341(11):837-9. PubMed ID: 10490384
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone: secretion and administration in catabolic adult patients, with emphasis on the critically ill patient.
    Voerman HJ; Strack van Schijndel RJ; de Boer H; van der Veen EA; Thijs LG
    Neth J Med; 1992 Dec; 41(5-6):229-44. PubMed ID: 1494402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein metabolism and the use of growth hormone and insulin-like growth factor-I in the critically ill patient.
    Carroll PV
    Growth Horm IGF Res; 1999 Dec; 9(6):400-13. PubMed ID: 10629160
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with growth hormone and insulin-like growth factor-I in critical illness.
    Carroll PV
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):435-51. PubMed ID: 11800516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone/insulin-like growth factor axis in critical illness.
    Gelato MC
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():1023-9. PubMed ID: 11086657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and splanchnic metabolic response to exogenous human growth hormone.
    Dahn MS; Lange MP
    Surgery; 1998 May; 123(5):528-38. PubMed ID: 9591005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whither growth hormone in the catabolic state of critical illness?
    Van Den Berghe G
    Growth Horm IGF Res; 1999 Dec; 9(6):397-9. PubMed ID: 10629159
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a role for growth hormone therapy in refractory critical illness?
    Taylor BE; Buchman TG
    Curr Opin Crit Care; 2008 Aug; 14(4):438-44. PubMed ID: 18614909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of growth hormone deficiency in adults.
    Nilsson AG; Svensson J; Johannsson G
    Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Still no indications that the treatment of growth hormone deficient adults with growth hormones is unsafe].
    Janssen JA; Visser WE; van der Lely AJ
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1486-9. PubMed ID: 15481571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety aspects of pharmacological GH therapy in adults.
    Carroll PV; Van den Berghe G
    Growth Horm IGF Res; 2001 Jun; 11(3):166-72. PubMed ID: 11735231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the IGF-IGFBP axis in critical illness.
    Baxter RC
    Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):421-34. PubMed ID: 11800515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A literature review of intensive insulin therapy and mortality in critically ill patients.
    Chen L
    Clin Nurse Spec; 2010; 24(2):80-6. PubMed ID: 20168143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
    Vespasiani Gentilucci U; Caviglia R; Picardi A; Carotti S; Ribolsi M; Galati G; Petitti T; Afeltra A; Cicala M
    Aliment Pharmacol Ther; 2005 May; 21(9):1063-71. PubMed ID: 15854167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
    Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
    Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing mortality in critically ill patients.
    Tiewala M; Perkevald A; Banerji MA; Ogrin C
    Curr Diab Rep; 2004 Jun; 4(3):210-2. PubMed ID: 15132887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.